Brain Health
Brain circuits driving overeating reveal new obesity treatment targets
Scientists map how brain reward and hunger systems malfunction to cause overeating, offering insights for better obesity treatments.
Research Paper
Apr 5, 2026 0
Results for "Semaglutide" in Parkinson's
42 articles
Metabolic Health
New GLP-1 Drug Design Shows Superior Weight Loss in Mice
Novel GLP-1 analogue NNC5840 achieves greater weight reduction than semaglutide by optimizing receptor signaling bias rather than potency.
Research Paper
Apr 5, 2026 0
Metabolic Health
GLP-1 Medications Transform Obesity Treatment Through Novel Mechanisms
New research explores how GLP-1-based drugs like Ozempic and Wegovy work to treat obesity beyond simple appetite suppression.
Research Paper
Apr 3, 2026 0
Metabolic Health
New Guidelines for GLP-1 Drugs During Surgery Address Safety Concerns
Expert consensus provides updated recommendations for managing popular weight-loss medications before and after surgery.
Research Paper
Apr 2, 2026 0
Metabolic Health
How GLP-1 Drugs Like Ozempic Actually Cause Weight Loss Through Brain and Body
New review explains the dual mechanisms behind GLP-1 receptor agonists' dramatic weight loss effects in both central and peripheral systems.
Research Paper
Apr 2, 2026 0
Metabolic Health
GLP-1 Weight Loss Drugs Lead to Significant Weight Regain After Stopping
Meta-analysis reveals patients regain substantial weight after discontinuing semaglutide, tirzepatide, and liraglutide therapy.
Research Paper
Apr 2, 2026 0
Longevity & Aging
Tirzepatide Shows Promise Against Semaglutide in Major Obesity Treatment Study
New research compares two leading GLP-1 medications for obesity treatment, potentially reshaping clinical practice.
Research Paper
Mar 31, 2026 0
Longevity & Aging
Oral Semaglutide Cuts Heart Disease Risk by 14% in High-Risk Diabetes Patients
Major trial shows oral diabetes drug significantly reduces cardiovascular events in nearly 10,000 high-risk patients over 4 years.
Research Paper
Mar 31, 2026 0
Metabolic Health
GLP-1 Drugs Plus Testosterone Therapy May Reverse Male Hormone Decline From Obesity
New research shows combining weight-loss medications with hormone therapy could transform health outcomes for obese men with low testosterone.
Research Paper
Mar 30, 2026 6
Metabolic Health
Nearly Half of Teen Obesity Prescriptions Never Filled, Study Reveals Troubling Gaps
Major study finds 43% of obesity medications prescribed to teens go unfilled, with Hispanic youth facing greatest barriers to access.
Research Paper
Mar 29, 2026 1
Longevity & Aging
Semaglutide Shows Promise for Reducing Alcohol Consumption in Clinical Trial
First randomized trial finds weekly semaglutide injections reduced alcohol craving and consumption in adults with alcohol use disorder.
Research Paper
Mar 29, 2026 0
Metabolic Health
GLP-1 Weight Loss Drugs Show Major Results But Raise Safety Questions
WHO-commissioned reviews find Ozempic and similar drugs deliver up to 16% weight loss, but long-term safety data remains limited.
Press Release
Mar 29, 2026 12
Page 1 of 4Next